Abstract P59: Impact of Drug Therapy on Refractory Angina
Bibliographic record
Abstract
Background: Revascularization is the ultimate therapeutic option for symptomatic angina patients on medical therapy. However, a continuously growing patient population presents with angiographic features not (any more) amenable to revascularization (refractory angina). The impact of medical therapy in refractory angina patients has not been evaluated. We sought to determine the symptom control in ‘spontaneous’ clinical practice and how this is affected by strict implementation of current guidelines for the management of chronic angina. Methods: Patients diagnosed with chronic stable angina who were not candidates for revascularization were included. Drug therapy over the last 4 weeks was recorded and patients were administered the Seattle Angina Questionnaire (SAQ). A 3 week period of drug insertion and/or titration was allowed. All patients were re-evaluated and repeated the SAQ at 6 months. Friedman's test with Bonferroni correction was used to compare difference in angina among the groups. A p value <0.05 was considered statistically significant. Results: A total of 118 patients were included (mean age 72 years; 71% males). Sixty-eight percent of patients were on beta-blockers (BB) (only 40% on maximally tolerated dose), 41% on calcium channel blockers (CCB), 81% on nitrates and 89% on aspirin. According to SAQ, 36% of patients suffered 3 or more angina episodes per week and 19% had heavy limitations in daily activities. At 6 months, 77% of patients were on maximally tolerated BB dose, 44% on CCB, 82% on nitrates and 93% on aspirin. SAQ score results improved significantly, with 20% of patients showing clinically important differences. Twenty-four percent of patients reported 3 or more angina episodes per week and 15% had heavy daily limitations. Conclusions: Refractory angina patients have a poor quality of life and often are not prescribed maximally tolerated drug therapy. Optimization of treatment regimen significantly improves quality of life but is clearly not sufficient for symptom control. Strategies for the treatment of this patient population are needed to be evaluate in clinical trials.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.001 | 0.000 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.001 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.000 |
| Insufficient payload (model declined to judge) | 0.000 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one teacher head, not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".